"10.1371_journal.pone.0068076","plos one","2013-07-09T00:00:00Z","Matteo Surdo; Emanuela Balestra; Patrizia Saccomandi; Fabiola Di Santo; Marco Montano; Domenico Di Carlo; Loredana Sarmati; Stefano Aquaro; Massimo Andreoni; Valentina Svicher; Carlo Federico Perno; Francesca Ceccherini-Silberstein","Department of Experimental Medicine and Surgery, University of Rome Tor Vergata, Rome, Italy; Clinical Infectious Diseases, Tor Vergata University (PTV), Rome, Italy; Department of Pharmaco-Biology, University of Calabria, Rende (CS), Italy, 4INMI L. Spallanzani, Rome, Italy","Conceived and designed the experiments: MS EB CFP. Performed the experiments: MS EB PS FDS MM. Analyzed the data: MS EB DDC SA VS CFP FCS. Contributed reagents/materials/analysis tools: LS MA. Wrote the paper: MS EB SA VS CFP FCS. Statistical Analysis: MS DDC.","CF Perno have received funds for attending symposia, speaking, organizing educational activities, grant research support, consultancy and advisory board membership, from Abbott, Boehringer Ingelheim, Bristol Myers Squibb, Gilead, Merck Sharp & Dohme, Janssen Cilag, Pfizer, Tibotec, Roche, and ViiV. F Ceccherini-Silberstein has received funds for attending symposia, speaking and organizing educational activities from Abbott, Merck Sharp & Dohme, Janssen Cilag, and ViiV. V Svicher has received funds for attending symposia, speaking and organizing educational activities from ViiV. The other authors declare that no competing interests exist. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","07","Matteo Surdo","MS",12,FALSE,3,5,7,6,TRUE,TRUE,FALSE,0,NA,FALSE
